BIOMAT Database Logo BIOMAT Database Logo

Dermatologic findings in HIV-1-infected patients: a prospective study with emphasis on CD4+ cell count. 1996

B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Sexually Transmissible Diseases Center, Hôpital Saint-Louis, Paris, France.

BACKGROUND Skin manifestations are common in patients infected with the human immunodeficiency virus (HIV) but the prognostic significance of may of them is not clear. METHODS Skin disorders were studied in a cohort of 267 HIV-infected patients followed prospectively and were correlated to the CD4+ cell count. RESULTS Among the most specific to HIV infection, Kaposi's sarcoma, oral hairy leukoplakia, molluscum contagiosum, xerosis and oral candidiasis were statistically associated to a low CD4+ cell count (200-300 CD4+/mm3; p < 0.001). Kaposi's sarcoma, oral candidiasis and molluscum contagiosum were more frequent in homosexual males (p < 0.05). Genital warts were more frequent in intravenous-drug users (p < 0.001). CONCLUSIONS These results suggest that dermatological findings are useful clinical predictors of the presence or progression of HIV infection.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts

Related Publications

B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
[Antigenemia and CD4+ cell count in HIV-1 infected patients].
January 1993, Medicina,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
CD4+ T-cell count and cerebrospinal fluid findings in HIV-infected patients with tuberculous meningitis.
November 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.
October 2005, AIDS (London, England),
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated.
January 2017, PloS one,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
April 2002, Japanese journal of infectious diseases,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Correlating CD4 count with mucocutaneous manifestations in HIV-positive patients: A prospective study.
January 2017, Indian journal of sexually transmitted diseases and AIDS,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.
October 2008, AIDS research and human retroviruses,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Association of aflatoxin B1 levels with mean CD4 cell count and uptake of ART among HIV infected patients: A prospective study.
January 2022, PloS one,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Absolute Lymphocyte Count as a Surrogate Marker of CD4 Count in Monitoring HIV Infected Individuals: A Prospective Study.
May 2016, Journal of clinical and diagnostic research : JCDR,
B Reynaud-Mendel, and M Janier, and J Gerbaka, and C Hakim, and C Rabian, and C Chastang, and P Morel
Prognostic value of the CD4+ T cell count for HIV-1 infected patients with advanced immunosuppression.
January 1996, International journal of STD & AIDS,
Copied contents to your clipboard!